Zoono Group Limited (ZNO.XA)

0.0610 -0.0130 (-17.57%) At close: 03:55PM AEST

Zoono Group Limited

24 Bishop Dunn Place
Unit 3 Botany South
Auckland 2013
New Zealand
64 2 165 9977
https://zoono.com

Sector(s): 
Industry: 
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Paul Ravlich CA, MBA	Chief Financial Officer	240.81k	N/A	N/A
Mr. Lewis Andrew Craig MacKinnon	Chief Operating Officer	162.61k	N/A	N/A
Mr. Paul Hyslop	MD & Director	274.27k	N/A	N/A
Ms. Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAIC	Company Secretary & Independent Non-Executive Director	76.55k	N/A	1973

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company's products include hand sanitizers, textile applicators, mould remediation, and surface sanitizers. It serves airlines, healthcare, childcare, facilities management, transportation, education, and hospitality sectors. The company was incorporated in 1986 and is headquartered in Auckland, New Zealand.

Corporate governance

Zoono Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.